Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Whitfield solution, commonly formulated as Whitfield's Ointment, is a topical dermatological preparation primarily used for the treatment of superficial fungal infections, particularly dermatophytoses like athlete's foot (tinea pedis) and ringworm (tinea corporis). It is also indicated for other skin conditions such as eczema, psoriasis, dandruff, seborrhoeic dermatitis, ichthyosis, acne, calluses, corns, and skin irritation and inflammation caused by burns or insect bites. The solution is a combination of two active ingredients: benzoic acid and salicylic acid. Benzoic acid acts as an antifungal and antibacterial agent, inhibiting the growth of fungi and bacteria. Salicylic acid is a keratolytic agent, which helps to shed rough or dead skin cells by reducing cohesion between keratinocytes and promoting exfoliation of the stratum corneum. This keratolytic action aids in the removal of infected tissue and enhances the penetration of benzoic acid. The synergistic effect of these two components makes it effective against various skin ailments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Whitfield solution.